comparemela.com

Latest Breaking News On - Rev nephrol - Page 1 : comparemela.com

Frontiers | The lived experience of immune-mediated noncommunicable diseases in relation to environmental change

Frontiers | The lived experience of immune-mediated noncommunicable diseases in relation to environmental change
frontiersin.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from frontiersin.org Daily Mail and Mail on Sunday newspapers.

EQS-News: ADQI Group Recognizes PenKid as Relevant Functional Biomarker for Sepsis-Associated Acute Kidney Injury

Issuer: SphingoTec GmbH / Key word(s): Research Update/Study results ADQI Group Recognizes PenKid as Relevant Functional Biomarker for Sepsis-Associated Acute Kidney Injury 04.04.2023 / 10:00 CET/CEST The issuer is solely responsible for the content of this announcement. The Acute Disease Qualit.

EQS-News: SphingoTec GmbH: ADQI Group Recognizes PenKid as Relevant Functional Biomarker for Sepsis-Associated Acute Kidney Injury

Effectiveness of a non-physician community health-care provider-led intensive blood pressure intervention versus usual care on cardiovascular disease (CRHCP): an open-label, blinded-endpoint, cluster-randomised trial

Type 2 diabetes

Type 2 diabetes accounts for nearly 90% of the approximately 537 million cases of diabetes worldwide. The number affected is increasing rapidly with alarming trends in children and young adults (up to age 40 years). Early detection and proactive management are crucial for prevention and mitigation of microvascular and macrovascular complications and mortality burden. Access to novel therapies improves person-centred outcomes beyond glycaemic control. Precision medicine, including multiomics and pharmacogenomics, hold promise to enhance understanding of disease heterogeneity, leading to targeted therapies.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.